We are live on ! Find out more
RGC

Redwood Grove Capital Portfolio holdings

AUM $395M
1-Year Est. Return 53.96%
This Fund
S&P 500
This Quarter Est. Return
+24.81%
1 Year Est. Return
+53.96%
3 Year Est. Return
+79.82%
5 Year Est. Return
+84.02%
10 Year Est. Return
–
AUM
$395M
AUM Growth
+$84.9M
Cap. Flow
+$13.3M
Cap. Flow %
3.37%
Top 10 Hldgs %
60.46%
Holding
27
New
5
Increased
6
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$18.6M
2
XYL icon
Xylem
XYL
+$11.5M
3
PRIM icon
Primoris Services
PRIM
+$8.19M
4
GFL icon
GFL Environmental
GFL
+$8.09M
5
ELAN icon
Elanco Animal Health
ELAN
+$5.4M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$15.9M
2
SHLS icon
Shoals Technologies Group
SHLS
+$11.6M
3
UCTT
Ultra Clean Holdings
UCTT
+$5.36M
4
SNY icon
Sanofi
SNY
+$3.93M
5
MRK icon
Merck
MRK
+$3.62M

Sector Composition

Rank Sector Weight
1 Industrials 29.04%
2 Healthcare 24.96%
3 Technology 24.29%
4 Communication Services 6.45%
5 Consumer Discretionary 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELAN icon
1
Elanco Animal Health
ELAN
$12B
$37.5M 9.51%
1,525,300
+233,500
+18% +$5.4M
XYL icon
2
Xylem
XYL
$26.6B
$29.1M 7.37%
246,112
+100,018
+68% +$11.5M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.18T
$25.5M 6.45%
72,081
-9,600
-12% -$3.43M
HUM icon
4
Humana
HUM
$46.2B
$23.5M 5.94%
59,070
-55,800
-49% -$15.9M
SW
5
Smurfit Westrock
SW
$25.9B
$23.2M 5.87%
500,636
+51,000
+11% +$2.11M
QCOM icon
6
Qualcomm
QCOM
$168B
$21.4M 5.42%
115,806
+6,800
+6% +$1.27M
IEX icon
7
IDEX
IEX
$17.2B
$20.9M 5.3%
92,100
– –
FSLR icon
8
First Solar
FSLR
$22.9B
$20.1M 5.09%
85,200
-9,200
-10% -$2.16M
TMO icon
9
Thermo Fisher Scientific
TMO
$231B
$19.5M 4.93%
+38,800
New +$18.6M
IQV icon
10
IQVIA
IQV
$42.4B
$18.1M 4.58%
93,500
– –
SHLS icon
11
Shoals Technologies Group
SHLS
$1.21B
$17.4M 4.42%
1,760,722
-1,276,700
-42% -$11.6M
IFF icon
12
International Flavors & Fragrances
IFF
$21.4B
$17.4M 4.41%
219,682
– –
AMRC icon
13
Ameresco
AMRC
$1.15B
$15M 3.8%
543,525
+74,000
+16% +$2.14M
UCTT
14
Ultra Clean Holdings
UCTT
$3.44B
$14.5M 3.67%
101,458
-60,900
-38% -$5.36M
ICFI icon
15
ICF International
ICFI
$1.6B
$14.1M 3.56%
192,852
+11,741
+6% +$811K
FISV
16
Fiserv Inc
FISV
$27.8B
$12.6M 3.2%
257,632
– –
GNRC icon
17
Generac Holdings
GNRC
$12.1B
$12.4M 3.14%
42,280
-7,000
-14% -$1.75M
BAC icon
18
Bank of America
BAC
$432B
$12.2M 3.08%
213,507
-35,100
-14% -$1.87M
ARRY icon
19
Array Technologies
ARRY
$721M
$9.86M 2.5%
1,330,267
-246,686
-16% -$1.97M
GFL icon
20
GFL Environmental
GFL
$14.9B
$7.87M 1.99%
+214,000
New +$8.09M
BRO icon
21
Brown & Brown
BRO
$24.3B
$7.47M 1.89%
116,400
– –
PRIM icon
22
Primoris Services
PRIM
$4.21B
$6.17M 1.56%
+62,291
New +$8.19M
OSK icon
23
Oshkosh
OSK
$9.7B
$4.88M 1.24%
+31,800
New +$4.48M
URI icon
24
United Rentals
URI
$68.2B
$2.55M 0.65%
2,249
– –
HURN icon
25
Huron Consulting
HURN
$2.59B
$1.73M 0.44%
+19,200
New +$2.2M
1
2

Similar funds

PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $395M AUM 23.17% 1-Year Est. Return
KC
Knuff & Co Foster City, California $395M AUM 24.52% 1-Year Est. Return
SC
Steph & Co Marinette, Wisconsin $395M AUM 20.8% 1-Year Est. Return
HP
Holowesko Partners Nassau, Bahamas $395M AUM 15.17% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
ACM
Aurdan Capital Management Wayne, Pennsylvania $394M AUM 19.7% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return
SSW
Stone Summit Wealth Miami, Florida $394M AUM 22.1% 1-Year Est. Return

Redwood Grove Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Redwood Grove Capital held 27 positions worth $395M, up 27% from $310M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Redwood Grove Capital deployed $13.3M of net new capital in Q2 2026, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was Thermo Fisher Scientific: 38,800 shares worth $19.5M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Humana, an estimated $15.9M trimmed.

  • Redwood Grove Capital's largest Q2 2026 buy was Thermo Fisher Scientific: 38,800 shares worth $19.5M.
  • Redwood Grove Capital added most to Xylem in Q2 2026, an estimated $11.5M increase.
  • Redwood Grove Capital's biggest Q2 2026 reduction was Humana, cutting an estimated $15.9M.
  • Redwood Grove Capital fully exited Sanofi in Q2 2026, selling an estimated $3.93M.
  • Redwood Grove Capital's ten largest holdings make up 60% of its $395M portfolio in Q2 2026.
  • Redwood Grove Capital opened 5 new positions and closed 2 in Q2 2026.
  • Redwood Grove Capital's portfolio value rose 27% quarter-over-quarter to $395M.

Based on Redwood Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.